[HTML][HTML] Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational new …, 2011 - Springer
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational New …, 2011 - infona.pl
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational new …, 2009 - europepmc.org
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
[引用][C] Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational New …, 2009 - cir.nii.ac.jp
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen
receptor negative human breast cancer cell lines | CiNii Research CiNii 国立情報学研究所 学術 …
receptor negative human breast cancer cell lines | CiNii Research CiNii 国立情報学研究所 学術 …
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational …, 2011 - pubmed.ncbi.nlm.nih.gov
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-edgar, S Taurin, L Larsen… - Investigational New …, 2011 - search.proquest.com
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
TJ Somers-Edgar, S Taurin, L Larsen… - Investigational New …, 2011 - infona.pl
Estrogen receptor (ER)-negative breast cancer is an aggressive form that currently requires
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
more drug treatment options. Thus, we have further modified cyclohexanone derivatives of …
